These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11533179)

  • 21. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
    Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
    AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
    Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
    Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations at the capsid-nucleocapsid cleavage site of gag polyprotein of Moloney murine leukemia virus abolish virus infectivity.
    Housset V; Darlix JL
    C R Acad Sci III; 1996 Feb; 319(2):81-9. PubMed ID: 8680959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.
    Lee SK; Nagashima K; Hu WS
    J Virol; 2005 Apr; 79(7):4159-69. PubMed ID: 15767417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between HIV-1 genome RNA dimerization, virion maturation and infectivity.
    Ohishi M; Nakano T; Sakuragi S; Shioda T; Sano K; Sakuragi J
    Nucleic Acids Res; 2011 Apr; 39(8):3404-17. PubMed ID: 21186186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.
    Larrouy L; Vivot A; Charpentier C; Bénard A; Visseaux B; Damond F; Matheron S; Chene G; Brun-Vezinet F; Descamps D;
    AIDS; 2013 Jan; 27(1):69-80. PubMed ID: 23018441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1.
    Coren LV; Thomas JA; Chertova E; Sowder RC; Gagliardi TD; Gorelick RJ; Ott DE
    J Virol; 2007 Sep; 81(18):10047-54. PubMed ID: 17634233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L; Yu XF
    Virology; 1998 Nov; 251(1):141-57. PubMed ID: 9813210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
    Accola MA; Höglund S; Göttlinger HG
    J Virol; 1998 Mar; 72(3):2072-8. PubMed ID: 9499062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation.
    Zhou J; Yuan X; Dismuke D; Forshey BM; Lundquist C; Lee KH; Aiken C; Chen CH
    J Virol; 2004 Jan; 78(2):922-9. PubMed ID: 14694123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors.
    Bally F; Martinez R; Peters S; Sudre P; Telenti A
    AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1209-13. PubMed ID: 10957718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perturbing HIV-1 Ribosomal Frameshifting Frequency Reveals a
    Benner BE; Bruce JW; Kentala JR; Murray M; Becker JT; Garcia-Miranda P; Ahlquist P; Butcher SE; Sherer NM
    J Virol; 2022 Jan; 96(1):e0134921. PubMed ID: 34643428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular localization of human immunodeficiency virus type 1 Gag and GagPol products and virus particle release: relationship with the Gag-to-GagPol ratio.
    Haraguchi H; Sudo S; Noda T; Momose F; Kawaoka Y; Morikawa Y
    Microbiol Immunol; 2010 Dec; 54(12):734-46. PubMed ID: 21091985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.
    Feng YX; Campbell S; Harvin D; Ehresmann B; Ehresmann C; Rein A
    J Virol; 1999 May; 73(5):4251-6. PubMed ID: 10196321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
    Paulus C; Ludwig C; Wagner R
    Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping of nucleocapsid residues important for HIV-1 genomic RNA dimerization and packaging.
    Kafaie J; Song R; Abrahamyan L; Mouland AJ; Laughrea M
    Virology; 2008 Jun; 375(2):592-610. PubMed ID: 18343475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.
    Pettit SC; Moody MD; Wehbie RS; Kaplan AH; Nantermet PV; Klein CA; Swanstrom R
    J Virol; 1994 Dec; 68(12):8017-27. PubMed ID: 7966591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation.
    Moore MD; Fu W; Soheilian F; Nagashima K; Ptak RG; Pathak VK; Hu WS
    Virology; 2008 Sep; 379(1):152-60. PubMed ID: 18657842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological characterization of the gag gene products of bovine immunodeficiency virus.
    Battles JK; Hu MY; Rasmussen L; Tobin GJ; Gonda MA
    J Virol; 1992 Dec; 66(12):6868-77. PubMed ID: 1331499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.